Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.

Kei M, Sato S, Yamaga R, Karaki S, Uesawa Y, Ito T

Open source

DOI
10.1248/bpb.b26-00050
Published
2026
Container
Biological & pharmaceutical bulletin
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1248/bpb.b26-00050,
  title = {Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.},
  author = {Kei M and Sato S and Yamaga R and Karaki S and Uesawa Y and Ito T},
  year = {2026},
  journal = {Biological \& pharmaceutical bulletin},
  doi = {10.1248/bpb.b26-00050},
  url = {https://doi.org/10.1248/bpb.b26-00050}
}

RIS

TY  - JOUR
TI  - Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.
AU  - Kei M
AU  - Sato S
AU  - Yamaga R
AU  - Karaki S
AU  - Uesawa Y
AU  - Ito T
PY  - 2026
JO  - Biological & pharmaceutical bulletin
DO  - 10.1248/bpb.b26-00050
UR  - https://doi.org/10.1248/bpb.b26-00050
ER  - 

APA

M, K., S, S., R, Y., S, K., Y, U., & T, I. (2026). Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.. Biological & pharmaceutical bulletin. https://doi.org/10.1248/bpb.b26-00050

Source records